Antitumoral use of cabazitaxel
    10.
    发明授权
    Antitumoral use of cabazitaxel 有权
    卡马西他唑的抗肿瘤用药

    公开(公告)号:US08927592B2

    公开(公告)日:2015-01-06

    申请号:US13456720

    申请日:2012-04-26

    申请人: Sunil Gupta

    发明人: Sunil Gupta

    摘要: The invention relates to a compound of formula: which may be in base form or in the form of a hydrate or a solvate, in combination with prednisone or prednisolone, for its use as a medicament in the treatment of prostate cancer, particularly metastatic prostate cancer, especially for patients who are not catered for by a taxane-based treatment.

    摘要翻译: 本发明涉及下式的化合物:其可以是碱形式或水合物或溶剂化物的形式,与泼尼松或泼尼松龙组合,用作治疗前列腺癌,特别是转移性前列腺癌的药物 ,特别是对于不接受紫杉烷治疗的患者。